Jan 14, 2026 6:01 am EST RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
Dec 8, 2025 7:43 pm EST RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
Oct 16, 2025 5:01 am EDT RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
Oct 1, 2025 6:01 am EDT RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
Sep 25, 2025 6:15 am EDT RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
Jun 27, 2025 3:28 pm EDT RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
Jun 13, 2025 5:15 am EDT RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
May 5, 2025 6:15 am EDT RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
Feb 20, 2025 6:30 am EST RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring